The group's principle activity is to provide medical devices for the treatment of occlusive vascular disease to interventional radiologists and vascular surgeons. The group also provides TRELLIS-8 Peripheral Infusion System, an isolated thrombolysis catheter that enables treatment of deep vein thrombosis and arterial occlusions by targeted delivery of clot-dissolving drugs. The group operates from United States.
